The six-gate roadmap, Strategy Lock through Phase 2 Enablement, shows that the sequencing discipline built for one IND is what determines whether a company’s development engine can repeat for a second and third program.
White Paper
From IND to Phase 2: The 24 Months That Determine Whether Your Development Platform Scales
Related Resources
All Resources
infographic
Cracking the Code: Syner-G’s Blueprint for Success with Pharmaceutical Stability Studies
Read More
white-paper
Stability Study Design: Pharmaceutical Stability and Data Evaluation
Read More
post
Biologics vs Small Molecules: A New Era in Drug Development
Read More
case-study
Syner-G Partners with Leading Supplier in Life Sciences to Build Out New cGMP Compliant Facilities
Read More
Let's move from science to success.
Let’s Talk